Abstract
In a 66-year-old man with autonomic failure, pyridostigmine (180 mg/day orally) improved both postural hypotension and underactive detrusor bladder dysfunction. Acetylcholinesterase inhibition may be useful in the management of orthostatic hypotension and bladder dysfunction in autonomic failure patients.
MeSH terms
-
Aged
-
Autonomic Nervous System Diseases / complications
-
Autonomic Nervous System Diseases / drug therapy*
-
Cholinesterase Inhibitors / therapeutic use*
-
Humans
-
Hypotension, Orthostatic / drug therapy*
-
Hypotension, Orthostatic / etiology
-
Male
-
Pyridostigmine Bromide / therapeutic use*
-
Urinary Bladder Diseases / drug therapy*
-
Urinary Bladder Diseases / etiology
Substances
-
Cholinesterase Inhibitors
-
Pyridostigmine Bromide